Santen Pharmaceutical Co Ltd
Santen Pharmaceutical's GHG Emissions Data Preview
In 2023, Santen Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Santen Pharmaceutical has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Santen Pharmaceutical's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Santen Pharmaceutical amounted to 39,612 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Santen Pharmaceutical increased by 3.32%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Santen Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Santen Pharmaceutical's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Santen Pharmaceutical were 17,021 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Santen Pharmaceutical reduced its Scope 1 emissions over time?
Since 2018, Santen Pharmaceutical's Scope 1 emissions have remained relatively, stable, indicating that Santen Pharmaceutical's emissions have plateaued with no significant change in its operational footprint.
Compared to the previous year (2022), Santen Pharmaceutical's Scope 1 emissions remained relatively stable, indicating that Santen Pharmaceutical's emissions have plateaued with no significant change in its operational footprint.
What are Santen Pharmaceutical's Scope 2 emissions?
In 2023, Santen Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 5,417 tCOâ‚‚e using the market-based method, and 22,591 tCOâ‚‚e using the location-based method.
Has Santen Pharmaceutical reduced its Scope 2 emissions over time?
Since 2018, Santen Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 31.79%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Santen Pharmaceutical's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Santen Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Santen Pharmaceutical use for Scope 2 reporting?
In 2023, Santen Pharmaceutical reported its Scope 2 emissions using the market-based method and using the location-based method.
Santen Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Santen Pharmaceutical's Value Chain Emissions
In 2023, Santen Pharmaceutical reported 196,579 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Santen Pharmaceutical includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Santen Pharmaceutical's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Santen Pharmaceutical's Scope 3 emissions?
In 2023, Santen Pharmaceutical reported total Scope 3 emissions of 196,579 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 99.83% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.17% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Santen Pharmaceutical reduced its Scope 3 emissions over time?
Since 2018, Santen Pharmaceutical's Scope 3 emissions have increased by 26.84%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2022), Santen Pharmaceutical's Scope 3 emissions increased by 47.3%, suggesting that the company faced challenges in reducing emissions across its value chain.
What categories of Scope 3 emissions does Santen Pharmaceutical disclose?
In 2023, Santen Pharmaceutical reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Santen Pharmaceutical's Scope 3 emissions?
In 2023, the largest contributors to Santen Pharmaceutical's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 102,440 tCOâ‚‚e (52.11%)
- Capital Goods (Cat. 2): 87,182 tCOâ‚‚e (44.35%)
- Fuel- and Energy-Related Services (Cat. 3): 3,189 tCOâ‚‚e (1.62%)
Santen Pharmaceutical's Scope 3 Emissions by Categories
Insights into Santen Pharmaceutical's Total Carbon Footprint
In 2023, Santen Pharmaceutical reported a total carbon footprint of 236,191 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 37.49% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Santen Pharmaceutical's total carbon footprint was Scope 3 emissions, accounting for 83.23% of the company's total carbon footprint, followed by Scope 2 emissions at 9.56%.